Repair of and checkpoint response to topoisomerase I-mediated DNA damage

被引：244

作者：

Pommier, Y ^{[1
]}

Redon, C ^{[1
]}

Rao, VA ^{[1
]}

Seiler, JA ^{[1
]}

Sordet, O ^{[1
]}

Takemura, H ^{[1
]}

Antony, S ^{[1
]}

Meng, LH ^{[1
]}

Liao, ZY ^{[1
]}

Kohlhagen, G ^{[1
]}

Zhang, HL ^{[1
]}

Kohn, KW ^{[1
]}

机构：

[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA

来源：

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | 2003年 / 532卷 / 1-2期

关键词：

topoisomerase; homologous recombination; camptothecin; Tdp1; Mre11; ATM; ATR; BRCA1; BRCA2; RAD52; RAD51; RPA; DNA-PK; cell cycle checkpoints;

D O I：

10.1016/j.mrfmmm.2003.08.016

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Topoisomerase I (Top1) catalyzes two transesterification reactions: single-strand DNA cleavage and religation that are normally coupled for the relaxation of DNA supercoiling in transcribing and replicating chromatin. A variety of endogenous DNA modifications, potent anticancer drugs and carcinogens uncouple these two reactions, resulting in the accumulation of Top I cleavage complexes. Top I cleavage complexes damage DNA and kill cells by generating replication-mediated DNA double-strand breaks (DSBs) and by stalling transcription complexes. The repair of Top1-mediated DNA lesions involves integrated pathways that are conserved from yeasts to humans. Top1-mediated DNA damage and cell cycle checkpoint responses can be studied biochemically and genetically in yeast and human cells with known genetic defects. Defects in these repair/checkpoint pathways, which promote tumor development, explain, at least in part, the selectivity of camptothecins and other Top I inhibitors for cancer cells. (C) 2003 Elsevier B.V. All rights reserved.

引用

页码：173 / 203

页数：31

共 50 条

[21] Molecular mechanisms of nucleolar DNA damage checkpoint response
Li, Jia
Yan, Shan
TRENDS IN CELL BIOLOGY, 2023, 33 (05) : 361 - 364
[22] Therapeutic Targeting of DNA Damage Response in Cancer
Choi, Wonyoung
Lee, Eun Sook
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[23] Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage
Huang, Ting-Hsiang
Chen, Hsiang-Chin
Chou, Shang-Min
Yang, Yu-Chen
Fan, Jia-Rong
Li, Tsai-Kun
CELL RESEARCH, 2010, 20 (09) : 1060 - 1075
[24] Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage
Xu, N.
Libertini, S.
Black, E. J.
Lao, Y.
Hegarat, N.
Walker, M.
Gillespie, D. A.
ONCOGENE, 2012, 31 (09) : 1086 - 1094
[25] Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs
Gioia, Ubaldo
Francia, Sofia
Cabrini, Matteo
Brambillasca, Silvia
Michelini, Flavia
Jones-Weinert, Corey W.
di Fagagna, Fabrizio d'Adda
SCIENTIFIC REPORTS, 2019, 9 (1)
[26] Coupling of Human DNA Excision Repair and the DNA Damage Checkpoint in a Defined in Vitro System*
Lindsey-Boltz, Laura A.
Kemp, Michael G.
Reardon, Joyce T.
Derocco, Vanessa
Iyer, Ravi R.
Modrich, Paul
Sancar, Aziz
JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (08) : 5074 - 5082
[27] Defective repair of topoisomerase I induced chromosomal damage in Huntington's disease
Palminha, Nelma M.
Souza, Cleide Dos Santos
Griffin, Jon
Liao, Chunyan
Ferraiuolo, Laura
El-Khamisy, Sherif F.
CELLULAR AND MOLECULAR LIFE SCIENCES, 2022, 79 (03)
[28] The DNA Damage Response-Repair or Despair?
Ljungman, Mats
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2010, 51 (8-9) : 879 - 889
[29] Exploiting the DNA Damage Response for Prostate Cancer Therapy
Stracker, Travis H.
Osagie, Oloruntoba I.
Escorcia, Freddy E.
Citrin, Deborah E.
CANCERS, 2024, 16 (01)
[30] DNA Damage Response: Three Levels of DNA Repair Regulation
Sirbu, Bianca M.
Cortez, David
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (08):

← 1 2 3 4 5 →